3002.12.00.10/Cryoprecipitated Antihemophilic Factor from Human Plasma/Canada

Cryoprecipitated Antihemophilic Factor from Human Plasma from Canada

Cryoprecipitate is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor, prepared by thawing frozen plasma at 1-6°C. It treats hemophilia A and fibrinogen deficiencies. Falls under HTS 3002.12.00.10 as a human blood fraction derived from plasma.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Provide CBER registration and lot-specific release certificates from FDA-licensed fractionators

• Declare exact protein content and potency per unit to avoid misclassification during entry

• Watch for expiration dating issues; expired plasma risks waste pharmaceutical classification under 3006

Cryoprecipitated Antihemophilic Factor from Human Plasma from Canada — Import Duty Rate | HTS 3002.12.00.10